Best Practices for Implementing Dual Endothelin Angiotensin Receptor Antagonist Therapeutics in Patients with IgAN - Module III

Nov 6, 2024

- Nov 5, 2025

Best Practices for Implementing Dual Endothelin Angiotensin Receptor Antagonist Therapeutics in Patients with IgAN

0.5

Claim your AMA PRA Category 1 Credit(s), CNE Contact Hour(s) or CPE Contact Hour(s) (CEUs) credit

This course is available for logged in users only. Please login or register to take the course.

Late Breaking Clinical Trial Data from AHA 2025 on Approved and Emerging Lipid Lowering Th...

Late-Breaking Clinical Trial Data from AHA 2025 on Approved and Emerging Lipid-Lowering Th...

Update on Long-Acting Nebulizers for Guideline-Based Maintenance Treatments for Patients w...